logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table HSR-10. Estimation of the total number of clients in treatment in 2010 or latest available year

CountryYearAll substitution clientsYear All treatment demand clients (TDI)YearTotal number of clients in treatment (ST24)Estimation of total number of clients in treatmentTotal adult population (15-64 ys) in 2010
Belgium(i)201017 62220105 36620105 36617 6227 147 512
Bulgaria(ii)20103 01220101 57320104 400(1)4 4005 211 619
Czech Republic(ii)20105 90020108 484200916 343(2)16 3437 413 560
Denmark(ii)20107 51520105 337201011 11911 1193 630 561
Germany(ii)201077 400201071 5072010164 804(3)164 80453 877 881
Estonia(i)20101 0642010665::1 064908 466
Ireland(ii)20108 72720108 511201017 238(4)17 2383 008 292
Greece(ii)20106 26420105 64520108 602(5)8 6027 539 573
Spain(ii)200978 311201052 5492010182 698182 69831 371 220
France(i)2010145 000201046 606201096 700(6)145 00041 966 225
Italy(ii)2010103 564201056 1462010176 430(7)176 43039 655 921
Cyprus(ii)201029420107672010884(8)884562 662
Latvia(iii)201023720101 73820101 738(9)1 7381 549 011
Lithuania(i)2010904201032820105239042 295 339
Luxembourg(i)20101 2482010230::1 248342 909
Hungary(ii)20101 03120104 54320096 917(10)6 9176 873 985
Malta(iii)20101 11920101 93620101 8751 936288 538
Netherlands(ii)201010 085201012 919201035 94335 94311 123 750
Austria(ii)201014 96220105 271200716 72616 7265 654 499
Poland(iii)20102 114201014 408201011 341(11)14 40827 223 082
Portugal(ii)201029 32520105 179201037 983(12)37 9837 119 943
Romania(iii)201060120102 16320102 163(13)2 16315 003 660
Slovenia(i)20103 545201079720103 332(14)3 5451 421 436
Slovakia(iii)201061020102 26620102 2262 2663 928 471
Finland(i)20091 80020101 364::1 8003 552 663
Sweden(iii)20073 11520106 424::6 4246 100 463
UK- England & Wales(ii)2009-10149 9492009-10225 844
UK-Scotland200622 2242010 (UK) 127 893::225 844 (UK) 40 988 182
UK-Northern Irel.2009-105432009-102 518
Croatia(iii)20105 03520107 55020107 5507 5502 972 315
Turkey(iii)2010:20102 90020102 659(15)2 90048 618 564
Norway(iii)20106 01520108 75020108 7508 7503 217 801
 

Notes:

Where data are not available for a country, the table entry is left empty.

(i) indicates that the clients considered to calculate the total estimation have been the substitution clients.

(ii) indicates that the clients considered to calculate the total estimation have been the total number of clients in treatment (ST24).

(iii) indicates that the clients considered to calculate the total estimation have been the all treatment demand clients (TDI).

See the data on number of clients in substitution treatment in Table HSR-3 part (i) .

See treatment demand data in Table TDI-2 part (ii) .

(1) Clients who have been in treatment because of opioid problem use (4000), cocaine or amphetamine problem use (200), including an estimate of the number of treated persons for hallucinogens, sedatives or cannabis (200).

(2) The information refers to all clients treated in 2009 for problems with illegal substances in outpatient healthcare facilites (2010 National Report; table 5-3: Number of clinics and number of addictive substance users treated in 2000-2009 (Nechanská et al. 2010; Institute of Health Information and Statistics, 2010a). This figure is an under-estimate as it only refers to clients being treated within these types of facilites and not all available treatment providers in the Czech Republic.

(3) No control for double-counting beyond centre level, estimates based on selected types of specialised treatment centres and extrapolated based on coverage estimates. Outpatient calculation based on 54.385 clients (no individual data, based on "last episode in a given year in a given centre" related to opiate-related disorders (F11.x), all treatments); inpatient calculation based on clients having ended a treatment episode in a given year. Additional source of information: 31.496 hospital treatments due to F11, unclear overlap with specialised treatment centres (estimates based on data from specialised outpatient treatment: 12.6-16.2% parallel treatment in discharge to hospitals). Additional source of information based on national substitution register: 77.400 registered clients in substitution treatment (for 34.6% of clients treated in outpatient specialised centres and 3.2% of inpatient clients, a parallel "substitution treatment" is recorded by treatment centres). Inpatient data was corrected by estimate

(4) Each case (episode) sought treatment for problem (illicit)drug use (excluding those who reported alcohol, hypnotic or sedatives as their main problem drug). The cases include those who reported one of the following as their main problem drug: an opiate, cocaine, a stimulant, hallucinogens, volatile inhalants and cannabis.

(5) The above data come from 68 officially recognized centres which offered treatment services in 2010 and delivered relevant data. They consist of 38 drug-free treatment programmes (of which 11 inpatient programmes for adults, 13 outpatient programmes for adults and 14 outpatient programmes for adolescents/young adults), 22 substitution treatment units (of which 6 methadone substitution units and 16 buprenorphine substitution units), 6 drug-free treatment programmes in prison and 1 outpatient detoxification program. The data collection is based on the “Treatment Questionnaire” (2010), which is a revised version of the “Treatment Unit Form/TUF A”. The collected information is controlled annually to check internal consistency. The figure does not include readmissions within the year in the same unit; whereas clearance for double entries among different units is not feasible.

(6) 90000 is the estimated number of patients who sought help in the outpatient treatment centers in 2008 for their problem with illegal drugs. Approximately 2000 people were accommodated in residential treatment centers and 4700 were welcomed for problems with illegal drugs in penal establishments in 2008. These numbers are estimates obtained from the activity reports sent by treatment centers once a year. About 90% of treatment centers provide these reports.

(7) Data refers to clients of the public drug outpatient treatment services (Ser.T.) in the year 2010.The total number of individual clients refers to clients who received treatment by Ser.T. for their drug problem. The clients can be treated in Ser.T. (outpatient service), in therapeutic communities (inpatient service) or in prison. The total number of treatment episodes refers to pharmacologically and/or psychosocial treatment performed by Ser.T. for clients who have drug problems. The clients can be treated in Ser.T. (outpatient service), in therapeutic communities (inpatient service) or in prison.

(8) The total number of persons in treatment in 2010 is controlled for double counts (clients entering treatment in the reporting year and those in treatment during the reporting year who had continued treatment from the previous year/s).

(9) All out-patient treatment clients according to Health Insurance Data, for which data in TDI (PREDA database) were reported. According to the Health Insurance Data additional 986 individual clients were treated in 2010 but were not reported in TDI.

(10) Data refers to opiates, amphetamines and cocaine users in treatment in 2009.

(11) Data come from the reporting system conducted by Institute of Psychiatry and Neurology covering only residential treatment due to mental and behavioural disorders caused by using illicit drugs. The residential system of statistical reporting is based on individual statistical questionnaires. Each questionnaire is coded. It is possible to eliminate double counting of persons who enter treatment several times a year, sometimes in many facilities.

(12) Individuals within at least one treatment episode during the reporting year. Includes: Opiates, Cocaine, stimulants, hypnotics and sedatives, hallucinogens,volatile and cannabis.

(13) Data sources: treatment centres under coordination of Ministry of Health, NAA, private centres and prisons. However not all centres (which are under coordination of Ministry of Health) have reported.

(14) Data source: TDI database.

(15) Inpatient data. All illlicit drug users included, volatile inhalants excluded.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

Standard Tables 24 (ST24) on 'treatment availability' submitted by NFPs in 2011.

Standard Table 34 (TDI): Characteristics of individuals starting treatment for drugs by type of treatment centre submitted by NFPs in 2011.

Reitox National Reports 2011.

Eurostat for the demographic data.

Page last updated: Monday, 09 July 2012